July 2018
TABLE OF CONTENTSCluster's lifeOur member's newsSave the dateCalls for projectsAround our themes

This month, discover our activities in video: companies listed on Euronext, clinicians attending the Clinical Innovation Day, new members involved in the cluster gouvernance: many testimonials attesting our dynamism and the one of our ecosystem !


The agenda for the 2nd semester is already full: Medical Device Information Day, H2020 Health Calls for projects, Skin Aging Day ...


By then, we wish you a beautiful summer filled with projects!


The Lyonbiopole team

Cluster's life

  Lyonbiopole, always more active as a network headAttracted by the support and expertise offered by the health competitiveness cluster, 21 new members have chosen to join Lyonbiopole, during the first half of 2018. Coming from the entire Auvergne-Rhône-Alpes region and with very different typologies, the arrival of these newcomers reflects the active recruitment work of the cluster and its economic attractiveness.
 Clinical Innovation Day on videoDr. Jérôme Holtzmann, psychiatrist and Dr. Gilles Boschetti, gastroenterologist at the HCL, give feedbacks on their participation in our Clinical Innovation Day and the prospective workshops. [...]
 "Nutrition, Inflammation and Immunity" workshopThe "Nutrition, Inflammation and Immunity" workshop was held during the Clinical Innovation Day, the 19th of June 2018. Researchers, clinicians and companies met to investigate the mechanisms governing the links between nutrition, inflammation and immunity and to identify different lines of innovation.
 Lyonbiopole's General AssemblyDiscover in pictures the testimony of our members regarding Lyonbiopole's support. Florence Agostino-Etchetto, CEO of Lyonbiopole, talks about the evolution of Lyonbiopole's governance. [...]
  Support to the GDPRAs part of our collaboration with our new associate member Delsol Avocats, several of our members were able to benefit from a day of support on the GDPR. Thanks to individual meetings, our members were able to benefit from a pre-diagnosis and a personalized discussion on the subject.
 Our companies listed on the stock exchange...Lyonbiopole and Euronext invite you to discover Theranexus, Genoway, Adocia and Geneuro, 4 member companies of Lyonbiopole giving feedbacks on their listing on the Euronext stock exchange.
 Singapore missionLyonbiopole, as part of its International Action Plan supported by the Auvergne Rhône-Alpes region, led a mission in Singapore in early July to meet the actors of a health innovation ecosystem that wants to become one of the main life sciences hubs in Asia. It is in this perspective that the major public or semi-public players (A-Star, EDB, JTC Corporation, Vertex) and private companies (VC or corporate venture funds, incubators, consultants) were all approached to help and support Lyonbiopole members who wish to create a subsidiary in Singapore to spread the word about Asia or to partner with Singaporean partners or investors.
  NovaDiscovery and Koelis win French Tech Pass #HealthTechTwo Lyonbiopole member companies will be part of the next French Tech Pass promotion and will benefit from premium support. Lyonbiopole, operator of the French Tech Health Pass in the AURA region, with the active participation of Lyon French Tech, brought together a committee composed of French Tech partners and investors. This committee auditioned the CEOs of NovaDiscovery and Koelis before allowing them unanimously to join the next national promotion. Companies have been selected on the basis of their turnover hyper-growth and are the first two regional nuggets to enter this restricted circle!

Our member's news

 Focus onFor the 20th anniversary of the I-LAB competition, the Ministry of Higher Education and Research has awarded and even awarded the Microlight3D Competition Grand Prize, and its 3D micro-printing technology derived from the University Grenoble-Alpes. [...]
 July 2nd, 2018New studies confirm anti-CD160 antibodies are potential therapeutics for ophthalmic diseases July 3th, 2018Poxel Completes Patient Enrollment for TIMES 1 Trial in the Phase 3 Registration Program for Imeglimin July 3th, 2018Biom'up announces first sales of HEMOBLASTTM Bellows in the United States
 July 3th, 2018Valneva Announces Significant Progress of its Lyme Disease Vaccine Candidate July 12th, 2018Biom'up obtains CE Mark for its HEMOBLASTTM Bellows Laparoscopic Applicator July 12th, 2018Brush by FasTeesh
 July 30th, 2018Biom'up present at the 8 th Strategic Council of Health Industries hosted by France?s Prime Minister

Save the date

 NORDIC LIFE SCIENCE DAYS – NLS DAYS 2018
September 10th, 2018
Aging Skin Day
September 25th, 2018
BIO JAPAN
October 8th, 2018
Collaborative Day
October 18th, 2018
10th Nosocomial Infections Day
November 20th, 2018
SAVE THE DATE : Private Inv¤stment Day
November 30th, 2018
  • Nordic Life Science Days 2018
    September 10th, 2018
  • BIO Japan
    October 8th, 2018

  • See All events

    Calls for projects

     

    EUROPE & INTERNATIONAL

  • UNITAID – Preventing deaths from cervical cancer
    Before August 27th, 2018
  • SME Instrument (phase 1)
    Before September 5th, 2018
  • Eurostars programme
    Before September 13th, 2018
  • Eurostars – Market driven R&D in innovative technologies applied to the food chain
    Before September 13th, 2018
  • H2020 Health / Call – Better Health and care, economic growth and sustainable health systems
    Before October 2nd, 2018
  • SME Instrument (phase 2)
    Before October 10th, 2018
  • H2020 Health / Call – Trusted digital solutions and Cybersecurity in Health and Care
    Before November 14th, 2018
  • H2020 Health / Call – Digital transformation in Health and Care
    Before April 24th, 2019
  • Around our themes

     
  • Marvelous : Second Scientific Day
    October 5th, 2018
  • Bâtiment Domilyon

    321, avenue Jean Jaurès

    69007 Lyon

    Tel. : +33 (0)4 72 76 53 30

    Fax : +33 (0)9 55 91 30 26

    www.lyonbiopole.com

    info@lyonbiopole.com

    TwitterLinkedInrss

     

    This email has been sent automatically to [[EMAIL_TO]]. Click here to unsubscribe.